Eli Lilly Employees Top-tier Investors 58.43% IRR Tachi Yamada, M.D. Turn- Key Facilities Scientific Expertise high-quality, cutting edge life science companies Exceptional Track Record 1.02 DPI Pfizer Ventures Leroy Hood, M.D., Ph.D. Penn State Entrepreneurs Neuroscience & Neurology Scientists & Technology Developers Diversity Sundar Kodiyalam CPRIT San Diego Office AI & Machine Learning Lewis Cantley Syndication Magnolia Neurosciences $12.3 Million NIDA Grant Abbvie Jan Lundberg, Ph.D. Case Western Reserve New York Office WRF Capital Operating Partners? Proniras Seattle Office The Rockefeller University Gates Foundation Uniformed Services University Corporate Spinouts Academic & Research Institutions Singapore Office WuXi PharmaTech Dana Farber Cancer Lydian Neurosciences Temasek Advisory & Corporate Boards Gates Foundation Bruce L.A. Carter, Ph.D. Harvard Medical School Strategic Partnerships Lodo Therapeutics Weill Cornell Medicine Oncology Venture Capital Rodeo Therapeutics (BARDA) – on updated slide deck MD Anderson Cancer Center Alexandria Venture Investments Weill Cornell Medicine 2.85 DVPI CSAB Members? Rodeo Therapeutics 2014 Top- quartile Ranked University of Minnesota $3.375 Billion Exit The Rockefeller University $1 Billion Genentech Collaboration ARCH Venture Partners Non- Dilutive Funding Targeted Therapeutic (Asset) Financing Columbia University Petra Pharma UT Southwestern Medical Center Capital- efficiency Infectious Disease, Oncology, Microbiome 150+ Years’ Experience Reviewed > 4,000 Opportunities Syndication Partners Gene Yeo, Ph.D. Steve Gillis, Ph.D. Substantial Exit History Apogen Biotechnologies Fund I net IRR of 58.4% UT Southwestern Lodo Therapeutics Divestitures Eli Lilly Employees Top-tier Investors 58.43% IRR Tachi Yamada, M.D. Turn- Key Facilities Scientific Expertise high-quality, cutting edge life science companies Exceptional Track Record 1.02 DPI Pfizer Ventures Leroy Hood, M.D., Ph.D. Penn State Entrepreneurs Neuroscience & Neurology Scientists & Technology Developers Diversity Sundar Kodiyalam CPRIT San Diego Office AI & Machine Learning Lewis Cantley Syndication Magnolia Neurosciences $12.3 Million NIDA Grant Abbvie Jan Lundberg, Ph.D. Case Western Reserve New York Office WRF Capital Operating Partners? Proniras Seattle Office The Rockefeller University Gates Foundation Uniformed Services University Corporate Spinouts Academic & Research Institutions Singapore Office WuXi PharmaTech Dana Farber Cancer Lydian Neurosciences Temasek Advisory & Corporate Boards Gates Foundation Bruce L.A. Carter, Ph.D. Harvard Medical School Strategic Partnerships Lodo Therapeutics Weill Cornell Medicine Oncology Venture Capital Rodeo Therapeutics (BARDA) – on updated slide deck MD Anderson Cancer Center Alexandria Venture Investments Weill Cornell Medicine 2.85 DVPI CSAB Members? Rodeo Therapeutics 2014 Top- quartile Ranked University of Minnesota $3.375 Billion Exit The Rockefeller University $1 Billion Genentech Collaboration ARCH Venture Partners Non- Dilutive Funding Targeted Therapeutic (Asset) Financing Columbia University Petra Pharma UT Southwestern Medical Center Capital- efficiency Infectious Disease, Oncology, Microbiome 150+ Years’ Experience Reviewed > 4,000 Opportunities Syndication Partners Gene Yeo, Ph.D. Steve Gillis, Ph.D. Substantial Exit History Apogen Biotechnologies Fund I net IRR of 58.4% UT Southwestern Lodo Therapeutics Divestitures
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Eli Lilly
Employees
Top-tier Investors
58.43% IRR
Tachi Yamada, M.D.
Turn-Key Facilities
Scientific Expertise
high-quality, cutting edge life science companies
Exceptional Track Record
1.02 DPI
Pfizer Ventures
Leroy Hood, M.D., Ph.D.
Penn State
Entrepreneurs
Neuroscience & Neurology
Scientists & Technology Developers
Diversity
Sundar Kodiyalam
CPRIT
San Diego Office
AI & Machine Learning
Lewis Cantley
Syndication
Magnolia Neurosciences
$12.3 Million NIDA Grant
Abbvie
Jan Lundberg, Ph.D.
Case Western Reserve
New York Office
WRF Capital
Operating Partners?
Proniras
Seattle Office
The Rockefeller University
Gates Foundation
Uniformed Services University
Corporate Spinouts
Academic & Research Institutions
Singapore Office
WuXi PharmaTech
Dana Farber Cancer
Lydian Neurosciences
Temasek
Advisory & Corporate Boards
Gates Foundation
Bruce L.A. Carter, Ph.D.
Harvard Medical School
Strategic Partnerships
Lodo Therapeutics
Weill Cornell Medicine
Oncology
Venture Capital
Rodeo Therapeutics
(BARDA) – on updated slide deck
MD Anderson Cancer Center
Alexandria Venture Investments
Weill Cornell Medicine
2.85 DVPI
CSAB Members?
Rodeo Therapeutics
2014 Top-quartile Ranked
University of Minnesota
$3.375 Billion Exit
The Rockefeller University
$1 Billion Genentech Collaboration
ARCH Venture Partners
Non-Dilutive Funding
Targeted Therapeutic (Asset) Financing
Columbia University
Petra Pharma
UT Southwestern Medical Center
Capital-efficiency
Infectious Disease, Oncology, Microbiome
150+ Years’ Experience
Reviewed > 4,000 Opportunities
Syndication Partners
Gene Yeo, Ph.D.
Steve Gillis, Ph.D.
Substantial Exit History
Apogen Biotechnologies
Fund I net IRR of 58.4%
UT Southwestern
Lodo Therapeutics
Divestitures